The role of quantitative ADME proteomics to support construction of physiologically based pharmacokinetic models for use in small molecule drug development

Publisher： John Wiley & Sons Inc

E-ISSN： 1862-8354|9|7-8|732-744

ISSN： 1862-8346

Source： PROTEOMICS - CLINICAL APPLICATIONS, Vol.9, Iss.7-8, 2015-08, pp. : 732-744

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of a Physiologically-Based Pharmacokinetic Model of the Rat Central Nervous System

By Badhan Raj K. Singh   Chenel Marylore   Penny Jeffrey I.  

Pharmaceutics, Vol. 6, Iss. 1, 2014-03 ,pp. : 97-136

MDPI

Access to resources Recommend Favorite

Development of a Human Physiologically Based Pharmacokinetic (PBPK) Toolkit for Environmental Pollutants

By Ruiz Patricia   Ray Meredith   Fisher Jeffrey   Mumtaz Moiz  

International Journal of Molecular Sciences, Vol. 12, Iss. 11, 2011-10 ,pp. : 7469-7480

MDPI

Access to resources Recommend Favorite

Novel magnetic supports for small molecule affinity capture of proteins for use in proteomics

By Sucholeiki Irving   Toledo-Sherman Leticia   Hosfield Christopher   Boutilier Kelly   DeSouza Leroi   Stover David  

Molecular Diversity, Vol. 8, Iss. 1, 2004-03 ,pp. : 9-19

Springer Publishing Company

Access to resources Recommend Favorite

Development of a Region-Specific Physiologically Based Pharmacokinetic Brain Model to Assess Hippocampus and Frontal Cortex Pharmacokinetics

By Zakaria Zaril   Badhan Raj  

Pharmaceutics, Vol. 10, Iss. 1, 2018-01 ,pp. : 14-14

MDPI

Access to resources Recommend Favorite

Prediction of Drug-Drug Interactions with Bupropion and Its Metabolites as CYP2D6 Inhibitors Using a Physiologically-Based Pharmacokinetic Model

By Xue Caifu   Zhang Xunjie   Cai Weimin  

Pharmaceutics, Vol. 10, Iss. 1, 2017-12 ,pp. : 1-1

MDPI

Access to resources Recommend Favorite